Led by FNL's Jeffrey Lifson, M.D. and Mary Carrington, Ph.D., the "HIV in 2024: Progress, Problems, and Prospects" symposium marks the third installment in the prestigious Hood College – Frederick National Laboratory Life Sciences Symposium series. This latest collaborative event builds on the enduring legacy of the Hood College–National Cancer Institute Oncogene meetings, which has served as a cornerstone of the scientific community in Frederick for more than two decades.
The Symposium, "HIV in 2024: Progress, Problems and Prospects" jointly organized by the Frederick National Laboratory for Cancer Research and Hood College, is set to bring together a diverse audience of scientists, clinicians and students.
The event will feature presentations from esteemed experts, offering a state-of-the-art overview of the latest developments in critical aspects of HIV/AIDS research, including epidemiology, prevention strategies and advancements in clinical care.
The symposium will also address the persistent challenges that confront the field and innovative approaches aimed at overcoming these obstacles, focusing particularly on facets of HIV investigation with the potential to reshape clinical care and bolster prevention efforts. This symposium will serve as a vital platform for knowledge exchange, fostering collaboration and pushing the boundaries of our understanding of HIV.
Symposium Topics
- HIV epidemiology, global and US Innovations in HIV vaccine design
- Non-vaccine prevention of HIV infection
- State-of-the-art in HIV treatment
- Chronic inflammation/co-morbidities in treated HIV infection
- CNS infection with HIV
- KSHV virology, epidemiology treatment
- Understanding the viral reservoir
- Strategies for definitive treatment/cure of HIV infection
- Gene therapy for HIV infection
- Communities affected by HIV
- Combatting medical disinformation in the Internet age
Register Hood College Frederick National Laboratory